BV6 promotes GBM cell migration and invasion through the activation of the noncanonical NF-κB pathway [215,219,220], including binding of RelB, p52, and p50 subunits to the DNA, and the induction of target genes, such as TNFα [215]. The gene discussed is CD40; the disease is glioblastoma.